Passage Bio Inc (PASG) — Cash Flow-to-Debt Ratio
Passage Bio Inc (PASG) has a Cash Flow-to-Debt Ratio of -0.11x as of September 2025, meaning its operating cash flow of $-4.85 Million could theoretically repay 0% of its total liabilities ($43.04 Million) in one year. See Passage Bio Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Passage Bio Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Passage Bio Inc across 7 annual periods. Also explore PASG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Passage Bio Inc (2018–2024)
Year-by-year debt coverage analysis for Passage Bio Inc. For market capitalisation and broader financial context, see market value of Passage Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.17x | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.26 Million | $39.26 Million | ▲ +28.9% |
| 2022 | -2.80x | $-118.21 Million | $42.18 Million | ▲ +19.6% |
| 2021 | -3.48x | $-126.88 Million | $36.42 Million | ▼ -0.8% |
| 2020 | -3.46x | $-80.52 Million | $23.29 Million | ▲ +63.1% |
| 2019 | -9.36x | $-39.90 Million | $4.26 Million | ▼ -2201.3% |
| 2018 | -0.41x | $-18.57 Million | $45.63 Million | — |